Hyperoxia Induces S-phase Cell-cycle Arrest and P21(Cip1/Waf1)-independent Cdk2 Inhibition in Human Carcinoma T47D-H3 Cells
Overview
Authors
Affiliations
Little is known about cell-cycle checkpoint activation by oxidative stress in mammalian cells. The effects of hyperoxia on cell-cycle progression were investigated in asynchronous human T47D-H3 cells, which contain mutated p53 and fail to arrest at G1/S in response to DNA damage. Hyperoxic exposure (95% O(2), 40-64 h) induced an S-phase arrest associated with acute inhibition of Cdk2 activity and DNA synthesis. In contrast, exit from G2/M was not inhibited in these cells. After 40 h of hyperoxia, these effects were partially reversible during recovery under normoxic conditions. The inhibition of Cdk2 activity was not due to degradation of Cdk2, cyclin E or A, nor impairment of Cdk2 complex formation with cyclin A or E and p21(Cip1). The loss of Cdk2 activity occurred in the absence of induction and recruitment of cdk inhibitor p21(Cip1) or p27(Kip1) in cyclin A/Cdk2 or cyclin E/Cdk2 complexes. In contrast, Cdk2 inhibition was associated with increased Cdk2-Tyr15 phosphorylation, increased E2F-1 recruitment, and decreased PCNA contents in Cdk2 complexes. The latter results indicate a p21(Cip1)/p27(Kip1)-independent mechanism of S-phase checkpoint activation in the hyperoxic T47D cell model investigated.
Haghshenas M, Firouzabadi N, Akbarizadeh A, Rashedinia M Res Pharm Sci. 2024; 18(6):663-675.
PMID: 39005566 PMC: 11246111. DOI: 10.4103/1735-5362.389956.
Hypoxia signaling in cancer: Implications for therapeutic interventions.
Zhuang Y, Liu K, He Q, Gu X, Jiang C, Wu J MedComm (2020). 2023; 4(1):e203.
PMID: 36703877 PMC: 9870816. DOI: 10.1002/mco2.203.
Hyperoxia Alters Ultrastructure and Induces Apoptosis in Leukemia Cell Lines.
De Bels D, Tillmans F, Corazza F, Bizzari M, Germonpre P, Radermacher P Biomolecules. 2020; 10(2).
PMID: 32059539 PMC: 7072400. DOI: 10.3390/biom10020282.
Liu H, Luo Q, Cui H, Deng H, Kuang P, Lu Y Oncotarget. 2018; 9(4):4318-4337.
PMID: 29435105 PMC: 5796976. DOI: 10.18632/oncotarget.23093.
Tiwari K, Chu C, Couroucli X, Moorthy B, Lingappan K Biochem Biophys Res Commun. 2014; 450(4):1345-50.
PMID: 24997337 PMC: 4216694. DOI: 10.1016/j.bbrc.2014.06.132.